Evidence map›Paper›PMID 31728058›Full record

ArticleLeukemia2020

Impact of interferon on a triple positive polycythemia vera.

Hugo Campario, Matthieu Mosca, Bernard Aral, Valentin Bourgeois, Pauline Martin, Antoine Brustel, Mathilde Filser, Christophe Marzac, Isabelle Plo, François Girodon

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Leukemia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Hugo CamparioService d'Hématologie Biologique, Pôle Biologie, CHU de Dijon, Dijon, France.
Matthieu MoscaGustave Roussy, INSERM, UMR 1170, Laboratoire d'Excellence GR-Ex, Villejuif, France.
Bernard AralLaboratoire de génétique chromosomique et moléculaire, Pôle Biologie, CHU de Dijon, Dijon, France.
Valentin BourgeoisService d'Hématologie Biologique, Pôle Biologie, CHU de Dijon, Dijon, France.
Pauline MartinService d'Hématologie Biologique, Pôle Biologie, CHU de Dijon, Dijon, France.
Antoine BrustelService d'Hématologie Biologique, Pôle Biologie, CHU de Dijon, Dijon, France.
Mathilde FilserService d'Hématologie Biologique, Pôle Biologie, CHU de Dijon, Dijon, France.
Christophe MarzacLaboratoire Hématologie-Immunologie, Département Biologie et Pathologie Médicales, Gustave Roussy, France.
Isabelle PloGustave Roussy, INSERM, UMR 1170, Laboratoire d'Excellence GR-Ex, Villejuif, France.ORCID http://orcid.org/0000-0002-5915-6910
François GirodonService d'Hématologie Biologique, Pôle Biologie, CHU de Dijon, Dijon, France. francois.girodon@chu-dijon.fr.
CHU Dijon Bourgogne · FRInserm · FRUniversité Paris-Sud · FRInstitut Gustave Roussy · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiviral AgentsPolycythemia VeraHumansInterferon-alphaJanus Kinase 1MutationSTAT1 Transcription FactorAntiviral AgentsInterferon-alphaJAK1 protein, humanJanus Kinase 1STAT1 protein, humanSTAT1 Transcription Factor

Identifiers

PMID31728058
OpenAlexW2989556248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.